Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein

Full text
Mancio, Rafael Dias ; Hermes, Tulio de Almeida ; Macedo, Aline Barbosa ; Mizobuti, Daniela Sayuri ; Rupcic, Ian Feller ; Minatel, Elaine
Total Authors: 6
Document type: Journal article
Source: PLoS One; v. 12, n. 8 AUG 7 2017.
Web of Science Citations: 3

Chronic inflammation and oxidative stress are striking features of Duchenne muscular dystrophy disease. Diacerhein is an anthraquinone, which exhibits anti-inflammatory and antioxidant properties. Based on their actions, the present study evaluated the effects of diacerhein against myonecrosis, oxidative stress and inflammatory response in the diaphragm muscle of mdx mice and compared these results to current treatment widely used in DMD patients, with a main focus on the impact of prednisone. The results demonstrated that diacerhein treatment prevented muscle damage indicated by a decrease in the IgG uptake by muscle fibers, lower CK levels in serum, reduction of fibers with central nuclei with a concomitant increase in fibers with peripheral nuclei. It also had an effect on the inflammatory process, decreasing the inflammatory area, macrophage staining and TNF-alpha and IL-1 beta content. Regarding oxidative stress, diacerhein treatment was effective in reducing the ROS and lipid peroxidation in the diaphragm muscle from mdx mice. Compared to prednisone treatment, our findings demonstrated that diacerhein treatment improved the dystrophic phenotype in the diaphragm muscle of mdx mice similar to that of glucocorticoid therapy. In this respect, this work suggests that diacerhein has a potential use as an alternative drug in dystrophino-pathy treatment and recommends that its anti-inflammatory and antioxidants properties in the dystrophic muscle should be better understood. (AU)

FAPESP's process: 13/17732-4 - In vivo and in vitro effect of the antiinflammatory and antioxidant on dystrophic muscle fibers of Mdx mice
Grantee:Elaine Minatel
Support type: Regular Research Grants
FAPESP's process: 14/01970-6 - Effect of Diacerein and vitamin E on dystrophic muscle fibers of mdx mice
Grantee:Rafael Dias Mâncio
Support type: Scholarships in Brazil - Doctorate